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Abstract
Motivation: Methylation of CpG dinucleotides is a prevalent epigenetic modification that is required for proper development
in vertebrates, and changes in CpG methylation are essential to cellular differentiation. Genome-wide DNA methylation assays
have become increasingly common, and recently distinct stages across differentiating cellular lineages have been assayed. How-
ever, current methods for modeling methylation dynamics do not account for the dependency structure between precursor and
dependent cell types.
Results: We developed a continuous-time Markov chain approach, based on the observation that changes in methylation state
over tissue differentiation can be modeled similarly to DNA nucleotide changes over evolutionary time. This model explicitly
takes precursor to descendant relationships into account and enables inference of CpG methylation dynamics. To illustrate our
method, we analyzed a high-resolution methylation map of the differentiation of mouse stem cells into several blood cell types.
Our model can successfully infer unobserved CpG methylation states from observations at the same sites in related cell types
(90% correct), and this approach more accurately reconstructs missing data than imputation based on neighboring CpGs (84%
correct). Additionally, the single CpG resolution of our methylation dynamics estimates enabled us to show that DNA sequence
context of CpG sites is informative about methylation dynamics across tissue differentiation. Finally, we identified genomic
regions with clusters of highly dynamic CpGs and present a likely functional example. Our work establishes a framework for
inference and modeling that is well-suited to DNA methylation data, and our success suggests that other methods for analyzing
DNA nucleotide substitutions will also translate to the modeling of epigenetic phenomena.
Availability: Source code and inferred methylation variation rate categories are available upon request.
Contact: tony.capra@vanderbilt.edu, kostka@pitt.edu
1 Introduction
DNA methylation is a common epigenetic modification es-
sential to organism development (Smith and Meissner, 2013).
In vertebrates, DNA is most commonly methylated at the
fifth carbon position on cytosine nucleotides (5mC) that are
followed by a guanine, so-called CpG sites. A family of
three DNA methyltransferase enzymes (DNMT1, DNMT3A,
DNMT3B) is responsible for the establishment and mainte-
nance of methylation state at the millions of CpG sites in most
mammalian genomes (Smith and Meissner, 2013). Recently
the ability to perform genome-wide assays of the methylation
state of individual CpGs has become a reality due to advances
in microarray and DNA sequencing technology. Several ap-
proaches that vary in their accuracy, biases, coverage, and cost
are commonly used; see Laird (2010) for a detailed review of
current methods.
Systematic screening of DNA methylation across tissue
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differentiation and development has improved our knowledge
of its role in these processes (Bock et al., 2012; Xie et al.,
2013). The methylation profile of the mammalian genome
is largely stable, but the methylation of specific genomic re-
gions changes dynamically across development, and differ-
ent cellular lineages have unique methylation profiles (Ziller
et al., 2013). Additionally, the DNA methylation state nearby
a gene’s transcription start site correlates with gene expression
(Xie et al., 2013), and the correct orchestration of methylation
changes is essential for proper cellular differentiation. Aber-
rant methylation changes may lead to tumorgenesis and other
diseases (Portela and Esteller, 2010; Tost, 2010; Hansen et al.,
2011; Bergman and Cedar, 2013).
Studies assaying DNA methylation often focus on the com-
parison of two types of conditions, like tumor vs. normal
tissue (Nordlund et al., 2013), or stem cells vs. lineage-
committed cells (Xie et al., 2013). However, the natural pro-
cess of cellular differentiation and development has an es-
sentially tree-like topology, in which precursor cell types are
connected to their descendants by edges, thereby forming a
so-called lineage tree (Frumkin et al., 2005). For example,
Figure 1 depicts a lineage tree for blood cell differentiation,
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where DNA methylation has been assayed in cell types rep-
resented by nodes (Bock et al., 2012). Independent pairwise
comparisons cannot accommodate this structure.
To address this issue, we introduce an approach to model
methylation state changes between cell types that explicitly
takes dependencies induced by the lineage tree into account.
In this setup, modeling methylation changes over develop-
mental time is in many ways reminiscent of describing DNA
nucleotide changes over evolutionary time (Figure 1). As a re-
sult, we adapt established continuous-time Markov models of
sequence evolution to fit this task. In addition to accommodat-
ing cell lineage relations during development, our approach
has the benefit that it works at single CpG dinucleotide reso-
lution and does not require the spatial aggregation of methy-
lation measurements across the genome. Finally, the anal-
ogy with models for DNA sequence evolution provides in-
tuitive means to handle missing data, which are common in
many DNA methylation datasets. During parameter estima-
tion, missing data can be marginalized over, and the equiva-
lent of joint ancestry reconstruction (Pupko et al., 2000) al-
lows efficient inference of the most likely methylation states
for unobserved data in context of the lineage tree.
As an illustration of our approach, we analyzed methyla-
tion data collected across the cell lineage tree in Figure 1
from Bock et al. (2012). On this dataset, our method enabled
the accurate reconstruction of missing methylation states. The
single CpG resolution of our analysis allowed us to discover
that the identity of neighboring dinucleotides is strongly cor-
related with CpG methylation dynamics at many sites the
mouse genome. Finally, using our predictions of CpG methy-
lation variability, we identified a cluster of highly dynamic
CpG sites that show evidence of enhancer activity in blood
cells.
2 Methods
2.1 Modeling methylation changes across tis-
sue differentiation
We model the dynamics of DNA methylation across cellu-
lar differentiation using an approach motivated by phyloge-
netic models. In the phylogenetic context, a continuous time
Markov chain is used to quantify DNA sequence changes be-
tween species over a known species tree. Intuitively, we adapt
this approach and replace the species tree with a cell lineage
tree and the four-state alphabet of DNA with a three-state al-
phabet based on methylation status. In our model, the cell lin-
eage tree consists of nodes that correspond to cell types and
edges
In order to model transitions between CpG methylation
states along edges of the cell lineage tree, we associate each
node with a discrete random variable Xi (1 ≤ i ≤ N , assum-
ingN nodes), which is dependent on its parents (i.e., its direct
precursor cell types) in the lineage tree. As in DNA sequence
evolution models, we use a continuous time Markov chain to
describe this dependency structure. Specifically, if nodes i
and j are connected in the lineage tree by an edge i → j of
length t, then the probability of the methylation state at node
j being l conditional on node i being in methylation state k is
given by
P (Xj = l|Xi = k) = [expm(Qt)]kl
for k, l ∈ {u, p, m} (Guttorp and Minin, 1995) . Q is a 3 × 3
rate matrix (or generator), and expm denotes the matrix ex-
ponential. We assume a time-reversible Markov chain with
equilibrium frequency pi, which implies Q is fully parame-
terized by three non-negative rate-parameters, {ai}, and pi.
In summary, our model is parameterized by ϑ, which con-
sists of: the topology of the lineage tree (which we assume
is fixed, known, and consists of N nodes and E edges), the
branch lengths {ti}Ei=1, the equilibrium frequencies {pii}3i=1,
and the rate parameters {ai}3i=1. The likelihood of an ob-
served methylation pattern x = {xi}Ni=1 is then
P (x|ϑ) =
N∏
i=1
Pϑ(Xi = xi|Xpa(i) = xpa(i))
where pa(i) is the parent of node i in the lineage tree. For the
root node we have P (X = i) = pii, and assuming indepen-
dence between methylation patterns at different CpG sites, we
have for the likelihood of all observed patterns D = {xi}Li=1
(assuming there are L CpG sites):
L(ϑ) = P (D|ϑ) =
L∏
i
P (xi|ϑ). (1)
In contrast to most applications dealing with DNA sequence
changes, non-leaf nodes can be observed in our setting. We
handle missing data by marginalization, i.e., summation over
all possible configurations of un-observed nodes in the lineage
tree, which can be done efficiently via the elimination algo-
rithm (Siepel and Haussler, 2005). Maximum likelihood pa-
rameter estimates are then obtained by maximizing Equation
(1) over branch lengths, equilibrium frequencies and rate pa-
rameters. In summary, we have adapted a well-know class of
models that is typically used in the context of DNA sequence
evolution to model the dynamics of methylation changes dur-
ing tissue differentiation.
2.2 Integrating rate heterogeneity
2.2.1 Modeling rate heterogeniety
The approach described so far models methylation dynamics
using the same process at all CpG sites in the genome, and
thereby assumes homogeneity of methylation dynamics. This
assumption is not always reasonable. For instance, CpGs lo-
cated in CpG islands have a propensity to be unmethylated
The number of expected transitions along an edge is (−1)∑i piiQiit, and
therefore we will enforce (−1)∑i piiQii = 1 and report t in units of ex-
pected methylation state transitions.
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Figure 1: CpG methylation dynamics can be mod-
eled with an approach inspired by phylogenetic
analysis of nucleotide substitutions. Left: A lineage
tree of sampled blood cell types during hematopoi-
etic differentiation with stem cells on top and ter-
minally differentiated cells on the bottom (see Sec-
tion 2.4 for details). The lineage tree takes the
role played by the species tree in the phyloge-
netic context. Right: Examples of methylation pat-
terns across differentiation (columns) for CpG sites
at different genomic locations. Each row corre-
sponds to a cell type in the linage tree on the left.
The white block represents missing data. The dis-
cretized methylation states are analogous to DNA
sequence data.
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(compared to other CpG sites), and a disposition to stay in
that state (Jones, 2012).
To address this issue, we incorporate rate heterogeneity into
our model using a mixture modeling approach similar to phy-
logenetic models for DNA changes under heterogeneous sub-
stitution rates. First, we assume a certain fraction (β) of CpG
sites to be invariant, i.e., they do not change their methylation
state during tissue differentiation. For the (1− β) fraction of
variable CpG sites, we assume M different equiprobable rate
categories {rm}Mm=1 such that the probability of methylation
pattern xi is now
P (xi|ϑ˜) = βP (xi|r0, ϑ) + (1− β) 1
M
M∑
m=1
P (xi|rm, ϑ),
where we have used the “rate category” r0 to denote invari-
ance and ϑ˜ to denote the new parameter set. For the invariant
term on right hand side above, P (xi|r0, ϑ) = pk if all methy-
lation states in xi are k (for k ∈ {u, p, m}) and zero otherwise.
For the variable part, we have P (xi|rm, ϑ) = P (xi|ϑ¯(m)),
where we use Equation (1), but with all branch lengths in ϑ
scaled by the factor rm. The scale factors {rm} are deter-
mined by a Gamma distribution with shape parameter α and
scale parameter 1/α (setting the scale parameter to 1/α en-
sures that the Gamma distribution has a mean of one). Next,
the probability density function of the Gamma distribution is
discretized by splitting its domain into M equal-mass bins
and setting rm equal to the mean conditional on bin m. Thus,
a single positive parameter α determines all M rates. The
additional parameters to account for rate variation between
CpG sites are: the fraction of invariant sites β, the frequen-
cies of invariant states {pi}3i=1, and the shape parameter α of
the Gamma distribution. Maximum likelihood estimates are
again obtained considering CpG sites as independent. In sum-
mary, we use the Γ+I model to account for rate heterogeneity
across different CpG sites.
2.2.2 Assigning CpG sites to rate categories:
To assign CpG sites to rate categories we use an em-
pirical Bayes approach (Galtier et al., 2005). Let ϑˆ
denote the maximum likelihood estimates for ϑ˜. We
assign methylation pattern xi to rate category mˆ =
argmaxmP (xi|rˆm, ϑˆ)P (m)/P (xi|ϑˆ), where P (m) = βˆ for
m = 0 and P (m) = (1− βˆ)/M for 1 ≤ m ≤M .
2.3 Reconstructing missing data
Our model, which we refer to as a “phylo-epigenetic” model,
can reconstruct missing or unobserved methylation states a
cell type. Intuitively, for a given CpG site, nearby cell types
in the lineage tree carry information about its likely methyla-
tion state. We quantify this relationship using joint maximum
likelihood ancestry reconstruction (Pupko et al., 2000). In
essence, assume methylation pattern xi contains one or more
missing values (i.e., unobserved methylation states). Fur-
ther assume the empirical Bayes procedure discussed above
assigns pattern xi to rate category m. Note that during
this procedure missing values in xi had been “marginal-
ized out”. Then, we assign the missing values in xi to the
methylation state configuration that maximizes the likelihood
P (xi|rˆm, ϑˆ). This can be efficiently computed, also for mul-
tiple missing values at the same site (Pupko et al., 2000).
This reconstruction strategy shares methylation state infor-
mation for a CpG site “vertically” across the lineage tree, and
is complementary to approaches leveraging “horizontal” cor-
relations between different but nearby CpG sites across the
genome.
2.4 Data sources and processing
We analyzed DNA methylation maps from 13 cell populations
from stages of a differentiation of adult mouse hematopoietic
stem cells to different blood lineages, which are available in
the Supplementary Material of Bock et al. (2012). The pu-
rified cell types were obtained at progressive levels of dif-
ferentiation, starting with hematopoietic stem cells (HSC),
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Figure 2: Lineage-tree-based reconstruction of
methylation state is more accurate than nearest-
neighbor-based reconstruction. We masked the
methylation status for 10,000 CpG sites in each
cell type and reconstructed these values using
“vertical” information from our lineage tree model
and “horizontal” information from neighboring
CpG sites. The lineage tree approach proved sig-
nificantly more accurate overall (90% vs. 84%)
and within every cell type except erythrocytes,
which have the longest branch length.
followed by multipotent progenitor cells (MPP1 and MPP2),
and progenitor cells of the lymphoid (CLP) and myeloid
(CMP) lineages. For the lymphoid progenitors, further dif-
ferentiated cells included T helper cells (CD4), T cells (CD8)
and B cells (BCELL). For myeloid progenitor cells, the next
stages were granulocyte-monocyte progenitors (GMP) and
megakaryocyte-erythroid progenitors (MEP); the former was
followed by monocytes (MONO) and granulocytes (GRAN),
whereas the latter was followed by erythrocytes (ERY). The
relationships between cell types are summarized in the lin-
eage tree in Figure 1. Bock et al. (2012) generated a methyla-
tion map for each cell type using reduced representation bisul-
fite sequencing (RRBS). We averaged the two RRBS repli-
cates for each cell type, and for each CpG site with RRBS
data, we discretized the methylation status into methylated
(> 0.8 methylated), partially methylated (between 0.1 and
0.8), and unmethylated (< 0.1) categories based on the frac-
tion of methylated reads for the site. Histograms of these
values showed clear peaks at the ends of the spectrum. We
defined CpG islands using the cpgIslandExt table for
the mm9 build of the mouse gene from the UCSC Genome
Browser (Kent et al., 2002). To estimate the parameters of the
model described in Section 2.2.1 we used the observed fre-
quencies (excluding CpGs with missing values) for {pi}3i=1,
and used the L-BFGS-B algorithm to obtain maximum likeli-
hood estimates for all other parameters.
3 Results
We applied our phylo-epigenetic model to an RRBS data set
tracing the differentiation of adult hematopietic stem cells
(Bock et al., 2012). This study queried a set of over two mil-
lion CpG sites at different stages during blood lineage differ-
entiation, and the assayed cell types with their relationships
are summarized in the lineage tree in Figure 1.
We fit a phylo-epigenetic model with four rate categories
(three variable and one invariant) to the discretized methy-
lation status of CpG sites along each chromosome (Meth-
ods). The maximum likelihood estimates of the model pa-
rameters qualitatively agree across chromosomes, and the re-
sulting model is consistent with several previous findings. In-
variant CpG sites are more prevalent than variable sites (Bock
et al., 2012; Ziller et al., 2013); 62% of CpGs are invariant
in our analysis, and 15%, 9%, and 14% fall into the slow,
medium, and fast rate categories, respectively. As expected,
the equilibrium distribution for variable states favors methy-
lated CpGs (i.e., pˆiu < pˆip < pˆim for all chromosomes). Con-
trasting the dynamics at variable and invariant CpG sites, we
find that invariant sites are most likely to remain unmethylated
during differentiation (61%), whereas variable sites are most
likely to be in methylated states (57%). The branch lengths
obtained in our fitted models reflect the number of expected
methylation state transitions between cell types, and we see
the longest branch lengths between MEP and ERY cells and
between HSC and MPP1 cells (t = 5.89 and t = 0.98 aver-
aged over chromosomes, respectively). These numbers cor-
respond to an expected fraction of CpG sites with observed
methylation changes of 23% for MEP→ERY and of 15% and
for HSC→MPP1, taking into account the prevalence of in-
variant sites and the different rate categories for variable sites.
In the next three sections, we present examples of how our
modeling approach enables analysis of methylation dynamics
across cellular differentiations.
3.1 Reconstructing unobserved methylation
states
Over the 2,079,144 CpG sites assayed over 13 cellular con-
texts in the blood differentiation data set, 5,940,467 out of
27,028,872 (22%) methylation states are missing, due to a
range of technical issues (Bock et al., 2012). Given the preva-
lence of missing data, we assessed the ability of our model to
reconstruct unobserved values using information from the ob-
served methylation status of the same sites at other nodes in
the lineage tree. Conceptually, this is akin to the problem of
ancestral sequence reconstruction for DNA substitution mod-
els (Pupko et al., 2000), but in the context of methylation, we
also have observed data on internal nodes of the tree.
For each cell type, we masked 10,000 CpG sites with mea-
sured methylation state, re-estimated model parameters on
data missing the masked methylation states, reconstructed the
masked values as described in the Methods, and then com-
pared the reconstructed methylation values with the actual
values.
The reconstructed methylation states are generally very ac-
curate (90% correct overall), with some differences in perfor-
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Figure 3: Methylation dynamics are influenced by DNA se-
quence context outside of CpG islands. (a) Invariant CpG
sites (gray circles) are the most common category in our anal-
ysis, and they are strongly enriched in CpG islands. The other
rate categories (red circles) are roughly equally likely in and
around CpG islands. Each dot represents an average over
evenly sized bins centered on the 16,024 CpG Islands. The
red dashed line gives the sum of the variable categories. (b)
The presence of adjacent CpG sites is strongly correlated with
CpG methylation dynamics outside of CpG islands. The ef-
fect of DNA sequence context is much weaker within CpG
islands. (c) Nearly all invariant CpG sites within CpG Is-
lands are unmethylated. Outside of CpG islands, the adjacent
CpG count for a site is strongly correlated with its methylation
state.
mance between different cell types (Figure 2). As expected,
the length of the edges connecting cell types is correlated with
the accuracy the reconstruction of missing values; the nodes
with the longest incident edges in the lineage tree (HSC and
ERY) are the most difficult to reconstruct.
To compare our model’s reconstruction with a baseline
method, we also reconstructed the methylation state of each
masked CpG based on the methylation state of its nearest
neighbor (in terms of genomic location) in the same cell
type. This type of reconstruction assumes a “horizontal”
(i.e., location-wise) correlation between methylation states of
neighboring CpG sites, whereas our approach can be viewed
as assuming a “vertical” (i.e., progenitor to descendant) cor-
relation between the same CpG site in neighboring cell types.
Overall, lineage tree based reconstruction performs bet-
ter than location-based reconstruction (Figure 2; 90% cor-
rect vs. 84% correct). However, we note that more sophis-
ticated methods have achieved higher performance (Zhang
et al., 2013) by integrating multiple complementary data
types. Stratifying reconstructed methylation states by our in-
ferred rate categories revealed that, unsurprisingly, lineage-
tree-based reconstruction performs worst for “fast” CpG sites,
i.e., those in the fastest rate category according to the empiri-
cal Bayes procedure.
3.2 DNA sequence context is correlated with
CpG methylation dynamics.
Having established that our approach can successfully recon-
struct unobserved methylation states, we now describe several
analyses that use our model’s estimates of CpG methylation
dynamics at single CpG resolution. Specifically, we show that
outside CpG islands, and particularly for CpGs in promot-
ers, the immediate DNA sequence content around CpG dinu-
cleotides is correlated with the variability of their methylation
state.
3.2.1 Local CpG sequence context correlates with
methylation dynamics outside CpG islands.
CpG islands are genomic regions with high CpG dinucleotide
frequency, in which methylation status has been reported to
influence gene expression (Illingworth and Bird, 2009; Jones,
2012). Here we study the methylation dynamics at these loci
by analyzing the rate category assigned to each CpG island
CpG dinucleotide for which methylation states were assayed.
As expected, we find that invariant CpG dinucleotides are
strongly enriched in CpG islands, and that this enrichment
falls off with increasing distance from the island (Figure 3a).
To obtain this aggregate view, we split the roughly 16,000
annnotated CpG islands into an equal number of bins and
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compared the inferred dynamics of CpG sites in these groups.
Low CpG content promoters were significantly less likely to
be in the invariant rate category (p ≈ 0; chi-squared test).
This pattern remained when CpG islands were not considered.
discretized flanking genomic regions into equal-sized non-
overlapping tiles. The averages for corresponding locations
across CpG island loci are shown as points. The strong invari-
ance of CpG islands is in agreement with the notion that CpG
islands tend to retain their methylated state (Jones, 2012).
Taking advantage of the single CpG resolution of our ap-
proach, we explored whether the enrichment of invariant CpG
dinucleotides is exclusive to CpG islands. We hypothesized
that local CpG content could be important, so we stratified
each CpG dicnucleotide by (i) whether its two neighboring
dinucleotides contain none, one, or two CpGs and (ii) whether
it is located inside a CpG island. For CpGs without neighbor-
ing CpG sites, those in CpG islands are strongly enriched for
invariance over those outside of CpG islands (factor 1.66), but
this enrichment decreases for CpGs with one or two neighbor-
ing CpGs (Figure 3b). In other words, outside of CpG islands,
local CpG sequence context is strongly correlated with the ab-
sence of methylation state changes across hematopoietic dif-
ferentiation.
Next, given the importance of invariant CpGs, we assessed
if there is a preference for methylated (or partially methy-
lated) states compared to unmethylated states among invari-
ant CpG sites. We find that invariant CpG sites in CpG is-
lands are almost always unmethylated (90%), which is ex-
pected from previous analyses (Jones, 2012). However, in-
variant CpG sites outside of CpG islands are significantly
more likely to be methylated (65% methylated and 28% un-
methylated; p ≈ 0, binomial test). We again hypothesized
that adjacent sequence context could influence methylation at
these sites. Figure 3c shows that invariant CpGs with neigh-
boring CpG dinucleotides outside CpG islands are more un-
methylated compared to their counterparts without neighbor-
ing CpG dinucleotides.
3.2.2 Low CpG content promoters are enriched for vari-
able CpG sites.
The previous subsection shows that local CpG context is as-
sociated with the dynamics of individual CpG sites in certain
settings. Promoter CpGs are known to be functionally impor-
tant and influenced by CpG content, so next we analyzed sin-
gle CpG dynamics in promoters with respect to their overall
CpG density.
The methylation state of CpGs in gene promoters is as-
sociated with transcription levels (Jones, 2012). In several
cell types, promoter methylation is negatively correlated with
gene expression, and the effect is strongest in promoters with
low CpG density (Xie et al., 2013). The rate category as-
signments from our model enabled us to test whether pro-
moter CpG content is also correlated with methylation dy-
namics across hematopoietic differentiation. Following Xie
et al. (2013), we defined “promoters” as regions 500 bp up-
stream and downstream of transcription start sites (TSSs), and
we analyzed CpG sites within this window for 19,244 mouse
genes. We stratified promoters into low and high CpG den-
sity groups. As seen in human data, the CpG density dis-
tribution surrounding the mouse TSSs has two peaks; one at
low (<0.034 CpG/bp) and one at high CpG density (≥0.034
CpG/bp).
The low CpG content promoters have a significantly higher
fraction of variable CpG sites compared to the high CpG pro-
moters (Figure 4; p ≈ 0, chi-squared test). Nearly all (88%)
of the high CpG promoter CpG sites were invariant across
the differentiation, while only 55% of the low CpG sites were
invariant. This pattern could be driven by the invariance of
CpG Islands (Figure 3) and their prevalence in high CpG con-
tent promoters, but the effect remained when CpG island sites
were removed (76% vs. 54%; p ≈ 0). These results are con-
sistent with the previous observation that the correlation be-
tween methylation state and gene expression is strongest in
low CpG promoters (Xie et al., 2013).
3.3 Identification of genomic regions with vari-
able methylation state
The CpG site rate category predictions from our model enable
us to identify genomic regions with frequent methylation state
changes across hematopoietic differentiation. To do this, we
discarded CpG dinuclotides in repeat masked regions (rmsk
track for mm9 from UCSC genome browser) and then identi-
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Figure 5: A block of highly variable
CpG sites has evidence of gene regula-
tory enhancer activity in several blood
cells. This region on chromosome
4 (mm9.chr4:116,976,784–116,976,912)
contains 16 CpG sites that our model
places in the fast rate category within 109
bp. The region is located within a CpG
island in an intron of the gene Rnf220,
a ubiquitin ligase. The DNA sequence
at this locus is strongly conserved across
placental mammals; this suggests that it is
likely functionally important. In addition,
functional genomics data collected by the
ENCODE project (ENCODE, 2012) sug-
gest that this locus is a regulatory en-
hancer in several blood cell types. It
overlaps a DNaseI hypersensitive site in
an erythroid progenitor (G1E), and it
has peaks of the H3K4me1 enhancer-
associated histone modification in B-cell
lymphoma cells (CH12), erythroblasts,
G1E cells, and megakaryocytes.
fied maximal subsets in the RRBS data, for which each site is
no more than 20 bp from the nearest other CpG in the subset.
We furhter filtered out short regions (<50bp), and focused
on regions without evidence for accelerated substitution rates
(average phyloP score from UCSC genome browser greater
than zero); this approach leaves 61,980 regions with a high
density of assayed CpGs that are between 50bp and 758bp
long (mean: 95.1bp). The density of fast (in terms of their an-
notated rate category) CpG sites in these regions ranges from
about 10% to 100%, with 2,662 sites exceeding 50%. Figure 5
shows the longest of the 207 regions with all constituent CpGs
in the fast rate category. This 129 bp region with 16 assayed
CpG sites overlaps a CpG island, has strong evolutionary se-
quence conservation across placental mammals, and displays
histone modifications correlated with transcriptional enhancer
activity in various blood-related cell types (ENCODE, 2012).
These attributes suggest a gene regulatory role for this locus.
4 Discussion
In this manuscript, we adapt phylogenetic Markov models,
which are prevalent in comparative genomics and statistical
genetics, to accurately and efficiently analyze DNA methy-
lation dynamics across lineage specification. As a proof of
concept, we model RRBS methylation data collected from 13
related stages of blood cell development (Bock et al., 2012).
Using our model, we illustrate that (i) CpG site methylation
status can be accurately reconstructed using data from related
cell types at the same site; (ii) the single CpG site resolution
of our methylation dynamics estimates enable the discovery
of attributes, such as DNA sequence context, that correlate
with CpG methylation dynamics; and (iii) our models facili-
tate the identification of genomic regions with highly variable
CpG methylation states that are likely functional.
There are many additional methodologies that could be
mapped from the rich reservoir of statistical genomics to the
application of modeling methylation dynamics. It will be ex-
citing to see which will prove most useful as genome-wide
methylation data continue to be collected to elucidate tissue
differentiation and development.
In Section 3.1, we demonstrated that progenitor–
descendant relationships in the lineage tree can be used to
accurately reconstruct the methylation status of CpG sites.
This approach is complementary to information provided
by other methods for reconstructing DNA methylation that
use neighboring CpG sites along the genome (Zhang et al.,
2013). Context-dependent epi-phylogenetic models that inte-
grate such “vertical” (i.e., progenitor to descendant) and “hor-
izontal” (i.e., distance on chromosome) relationships
In addition, our strategy is subject to the discretization of
methylation status in a population of cells into discrete methy-
lation states. The three states and the thresholds we employ
are supported by the distribution of methylation values in our
data, but including direct modeling of counts of methylated
vs. unmethylated instances of a CpG site (Ziller et al., 2013)
into our approach could be a promising further direction.
Finally, DNA methylation is just one of several dy-
namic epigenetic/biochemical modifications regulating pre-
cise spatio-temporal gene expression patterns that are es-
sential for proper development. The “phylo-epigenetic” ap-
proach we have demonstrated here provides an integrative,
multivariate framework for modeling any epigenetic changes
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across multiple cell types and lineages. As phylogenetic mod-
els proved essential in the identification and interpretation
of functional DNA sequence regions, we believe that phylo-
epigenetic models can play a similar role in developing a
deeper understanding of epigenetic phenomena and their roles
in tissue differentiation and vertebrate development.
Acknowledgement
Funding: JAC was supported by institutional funds from
Vanderbilt University, DK was supported by institutional
funds from the University of Pittsburgh School of Medicine.
References
Bergman, Y. and Cedar, H. (2013). DNA methylation dy-
namics in health and disease. Nat Struct Mol Biol, 20(3),
274–281.
Bock, C., Beerman, I., Lien, W.-H., Smith, Z. D., Gu, H.,
Boyle, P., Gnirke, A., Fuchs, E., Rossi, D. J., and Meissner,
A. (2012). DNA Methylation Dynamics during In Vivo
Differentiation of Blood and Skin Stem Cells. Mol Cell,
47(4), 633–647.
ENCODE (2012). An integrated encyclopedia of DNA ele-
ments in the human genome. Nature, 489(7414), 57–74.
Frumkin, D., Wasserstrom, A., Kaplan, S., Feige, U., and
Shapiro, E. (2005). Genomic Variability within an Organ-
ism Exposes Its Cell Lineage Tree. PLoS Comput Biol,
1(5), e50.
Galtier, N., Gascuel, O., and Jean-Marie, A. (2005). Markov
models in molecular evolution. In R. Nielsen, editor,
Statistical Methods in Molecular Evolution, pages 3–24.
Springer, New York.
Guttorp, P. and Minin, V. N. (1995). Stochastic Modeling of
Scientific Data. Chapman and Hall/CRC.
Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Lang-
mead, B., McDonald, O. G., Wen, B., Wu, H., Liu, Y.,
Diep, D., Briem, E., Zhang, K., Irizarry, R. A., and Fein-
berg, A. P. (2011). Increased methylation variation in epi-
genetic domains across cancer types. Nat Genet, 43(8),
768–775.
Illingworth, R. S. and Bird, A. P. (2009). CpG islands – ’A
rough guide’. FEBS Letters, 583(11), 1713–1720.
Jones, P. A. (2012). Functions of DNA methylation: islands,
start sites, gene bodies and beyond. Nat Rev Genet, 13(7),
484–492.
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M.,
Pringle, T. H., Zahler, A. M., and Haussler, D. (2002). The
Human Genome Browser at UCSC. Genome Research,
12(6), 996–1006.
Laird, P. W. (2010). Principles and challenges of genome-
wide DNA methylation analysis. Nat Rev Genet, 11(3),
191–203.
Nordlund, J., Backlin, C., Wahlberg, P., Busche, S., Berglund,
E., Eloranta, M.-L., Flaegstad, T., Forestier, E., Frost, B.-
M., Harila-Saari, A., Heyman, M., Jonsson, O., Larsson,
R., Palle, J., Ronnblom, L., Schmiegelow, K., Sinnett, D.,
Soderhall, S., Pastinen, T., Gustafsson, M., Lonnerholm,
G., and Syvanen, A.-C. (2013). Genome-wide signatures
of differential DNA methylation in pediatric acute lym-
phoblastic leukemia. Genome Biology, 14(9), r105.
Portela, A. and Esteller, M. (2010). Epigenetic modifications
and human disease. Nat Biotech, 28(10), 1057–1068.
Pupko, T., Pe, I., Shamir, R., and Graur, D. (2000). A Fast Al-
gorithm for Joint Reconstruction of Ancestral Amino Acid
Sequences. Molecular Biology and Evolution, 17(6), 890–
896.
Siepel, A. and Haussler, D. (2005). Phylogenetic hidden
Markov models. In R. Nielsen, editor, Statistical Meth-
ods in Molecular Evolution, pages 325–351. Springer, New
York.
Smith, Z. D. and Meissner, A. (2013). DNA methylation:
roles in mammalian development. Nat Rev Genet, 14(3),
204–220.
Tost, J. (2010). DNA Methylation: An Introduction to the Bi-
ology and the Disease-Associated Changes of a Promising
Biomarker. Molecular Biotechnology, 44(1), 71–81.
Xie, W., Schultz, M. D., Lister, R., Hou, Z., Rajagopal, N.,
Ray, P., Whitaker, J. W., Tian, S., Hawkins, R. D., Le-
ung, D., Yang, H., Wang, T., Lee, A. Y., Swanson, S. A.,
Zhang, J., Zhu, Y., Kim, A., Nery, J. R., Urich, M. A.,
Kuan, S., Yen, C.-a., Klugman, S., Yu, P., Suknuntha, K.,
Propson, N. E., Chen, H., Edsall, L. E., Wagner, U., Li, Y.,
Ye, Z., Kulkarni, A., Xuan, Z., Chung, W.-Y., Chi, N. C.,
Antosiewicz-Bourget, J. E., Slukvin, I., Stewart, R., Zhang,
M. Q., Wang, W., Thomson, J. A., Ecker, J. R., and Ren,
B. (2013). Epigenomic Analysis of Multilineage Differ-
entiation of Human Embryonic Stem Cells. Cell, 153(5),
1134–1148.
Zhang, W., Spector, T. D., Deloukas, P., Bell, J. T., and
Engelhardt, B. E. (2013). Predicting genome-wide DNA
methylation using methylation marks, genomic position,
and DNA regulatory elements. ArXiv e-prints.
Ziller, M. J., Gu, H., Muller, F., Donaghey, J., Tsai, L. T. Y.,
Kohlbacher, O., De Jager, P. L., Rosen, E. D., Bennett,
D. A., Bernstein, B. E., Gnirke, A., and Meissner, A.
(2013). Charting a dynamic DNA methylation landscape
of the human genome. Nature, 500(7463), 477–481.
8
